Treatment of depression in patients with epilepsy: Problems, pitfalls, and some solutions

Epilepsy and Behavior

Volumn 4, Issue SUPPL. 3, 2003, Pages

  Krishnamoorthy, Ennapadam S ^a,b,c,d,e  

^a Public Health Centre   (India)

^b VHS Medical Centre India   (India)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e Gauri Shankar   (India)

Author keywords

Comorbidity; Depression; Epilepsy; Medical therapy; Psychological therapy; Transcultural issues

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; CLOBAZAM; CLONAZEPAM; FLUOXETINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

BEHAVIOR THERAPY; CLINICAL RESEARCH; COGNITION; COMORBIDITY; CULTURAL ANTHROPOLOGY; DEPRESSION; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; EPILEPSY; FAMILY THERAPY; GROUP THERAPY; HUMAN; MEDICAL LITERATURE; PATIENT COUNSELING; POPULATION RESEARCH; PSYCHIATRIC TREATMENT; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; SUPPORT GROUP; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 0344445519     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2003.08.017     Document Type: Review

References (71)

1. Simon B. Mind and madness in ancient Greece. Ithaca, NY: Cornell Univ. Press; 1978.
2. Lewis AJ. Melancholia: a historical review. J Ment Sci 1934;80: 1-42.
3. Krishnamoorthy ES. Psychiatric issues in epilepsy. Curr Opin Neurol 2001; 14:217-24.
4. Krishnamoorthy ES. The treatment of psychiatric disorders in epilepsy. In: Shorvon S, et al., editors. The treatment of epilepsy. 2nd ed. London: Blackwell Scientific; in press.
5. Slater E, Beard AW. The schizophrenia-like psychosis of epilepsy. Br J Psychiatry 1963;109:95-112.
6. Landolt H. Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attacks. In: Lorentz de Haas AM, editor. Lectures on epilepsy. Amsterdam: Elsevier; 1958. p. 91-133.
7. Kanner A, Balabanov A. Depression and epilepsy: how closely related are they? Neurology 2002;58(8 Suppl 5):S27-39.
8. Trimble MR. New antiepileptic drugs and psychopathology. Neuropsychobiology 1998;38:149-51.
9. Ketter TA, Malow BA, Flamini R, White SR, Post RM, Theodore WH. Anticonvulsant withdrawal-emergent psychopathology. Neurology 1994;44:55-61.
10. Anhoury S, Brown RJ, Krishnamoorthy ES, Trimble MR. Psychiatric outcome following temporal lobectomy: a predictive study. Epilepsia 2000;41:1608-15.
11. Fisher RS, Vickrey BG, Gibson P, et al. The impact of epilepsy from the patient's perspective. I. Descriptions and subjective perceptions. Epilepsy Res 2000;41:39-51.
12. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 1996;128:115-29.
13. Krishnamoorthy ES, Trimble MR. Forced normalization: clinical and therapeutic relevance. Epilepsia 1999;40(Suppl 10):S57-64.
14. Kellner CH, Bernstein HJ. ECT as a treatment for neurologic illness. In: Coffey CE, editor. The clinical science of electroconvulsive therapy. Spiegel D, series editor. Progress in psychiatry. Washington, DC: American Psychiatric Press; 1993;38:183-312.
15. Blumer D. Dysphoric disorders and paroxysmal effects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry 2000:8:8-17.
16. Krishnamoorthy ES. An approach to classifying psychiatric disorders in epilepsy. Epilepsy Behav 2000;1:373-7.
17. Lambert M, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(Suppl 10):S21-47.
18. Goldstein MA, Harden CL. Epilepsy and anxiety. Epilepsy Behav 2000;1:228-34.
19. Goldberg D, Huxley P. Common mental disorders: a biosocial model. London: Tavistock/Routledge; 1992.
20. Krishnamoorthy ES, Vijayaraghavan L, Brown RJ, Redhead K, Hakin N, Trimble MR. Prevalence and patterns of psychopathology in epilepsy: a prospective primary care based study in Great Britain. Epilepsia 2001;42(Suppl 2):120.
21. Newsom-Davis I, Goldstein LH, Fitzpatrick D. Fear of seizures: an investigation and treatment. Seizure 1998;7:101-6.
22. Murray CJL, Lopez AD, editors. The global burden of disease. Boston: Harvard Univ. Press; 1996.
23. Klerman GL, Lavori PW, Rice J, et al. Birth-cohort trends in rates of major depressive disorder among relatives of patients with affective disorder. Arch Gen Psychiatry 1985;42:689-93.
24. McCall WV. Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 2001;4:315-24.
25. Post RM. Mood disorders: somatic treatments. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. 6th ed. Baltimore: Williams & Wilkins; 1995. p. 1152-78.
26. Nemeroff CB, Owens MJ. Treatment of mood disorders. Nat Neurosci Suppl 2002;5:1068-70.
27. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002;63:963-71.
28. Scott J. Cognitive therapy of affective disorders: a review. J Affect Disord 1996;37:1-11.
29. Priest RG, Vize C, Roberts A, Roberts M, Tylee A. Lay people's attitudes to treatment of depression: results of an opinion poll for the Defeat Depression campaign just before launch. BMJ 1996;313:858-9.
30. Fava GF, Rafanelli C, Grandi S, Conti S, Belluardo P. Prevention of recurrent depression with cognitive behavioral therapy. Arch Gen Psychiatry 1998;55:816-20.
31. Klerman GL, Weissmann MM. Interpersonal psychotherapy and drugs in the treatment of depression. Pharmacopsychiatry 1987;20:3-7.
32. Segal Z, Vincent P, Levitt A. Efficacy of combined, sequential, and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. J Psychiatry Neurosci 2002;27:281-90.
33. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy pharmacotherapy combinations. Arch Gen Psychiatry 1997;54:1009-15.
34. Paykel ES, Scott J, Teasdale JD, et al. Prevention of relapse in residual depression by cognitive therapy. Arch Gen Psychiatry 1999;56:829-35.
35. Frank E, Grochocinski VJ, Spanier CA, et al. Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression. J Clin Psychiatry 2000;61:51-7.
36. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in outpatients with recurrent depression. Br J Psychiatry 1997;171:328-34.
37. Fava G, Grandi S, Zielezny M, Canestrari R, Morphy MA. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994; 151:1295-9.
38. Fava G, Silvana G, Zielezny M, Rafanelli C, Canestrari R. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996:153: 945-7.
39. Fava G, Silvana G, Zielezny M, Canestrari R, Morphy MA. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1998;155:1443-5.
40. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000;68:613-23.
41. Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy: a double-blind trial. J Affect Disord 1985;9:127-36.
42. McConnell HW, Duncan D. Treatment of psychiatric comorbidity in epilepsy. In: McConnell HW, Snyder PJ, editors. Psychiatric comorbidity in epilepsy: basic mechanisms, diagnosis, and treatment. Washington. DC: American Psychiatric Press: 1998. p. 245-361.
43. Andersen BB, Mikkelsen M, Vesterager A, et al. No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Res 1991;10:201-4.
44. Waechter F. Paroxetine must not be given to patients under 18. BMJ 2003;326:1282.
45. Monaco F, Cicolin A. Interactions between anticonvulsant and psychoactive drugs. Epilepsia 1999;40(Suppl 10):S71-6.
46. Bonnet U. Moclobemide: therapeutic use and clinical studies. CNS Drug Rev 2003:9:97-140.
47. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002;25: 91-110.
48. Endicott J. History, evolution, and diagnosis of premenstrual dysphoric disorder. J Clin Psychiatry 2000;61(Suppl 12):5-8.
49. Schmidt D. Vagus nerve stimulation for the treatment of epilepsy. Epilepsy Behav 2001;2:S1-5.
50. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000;1:93-9.
51. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000;42:203-10.
52. George MS. Summary and future directions of therapeutic brain stimulation: neurostimulation and neuropsychiatric disorders. Epilepsy Behav 2001;2:895-S100.
53. Gatzonis SD, Stamboulis E, Siafakas A. Acute psychosis and EEG normalisation after vagus nerve stimulation (letter). J Neurol Neurosurg Psychiatry 2000;69:278-9.
54. Ramaratnam S, Baker GA, Goldstein L. Psychological treatments for epilepsy (Cochrane Review). Cochrane Database Syst Rev 2001;4:CD002029.
55. Beck AT. Cognitive therapy: past, present, and future. J Consult Clin Psychol 1993;61:194-8.
56. Goldstein LH. Behavioural and cognitive-behavioural treatments for epilepsy: a progress review. Br J Clin Psychol 1990;29(Pt 3):257-69.
57. Ridsdale L, Kwan I, Cryer C. The effect of a special nurse on patients' knowledge of epilepsy and their emotional state. Epilepsy Evaluation Care Group. Br J Gen Pract 1999;49:285-9.
58. Ridsdale L, Kwan I, Cryer C. Newly diagnosed epilepsy: can nurse specialists help? A randomized controlled trial. Epilepsy Care Evaluation Group. Epilepsia 2000;41:1014-9.
59. Andrews DJ, Reiter JM, Schonfeld W, Kastl A, Denning P. A neurobehavioral treatment for unilateral complex partial disorders: a comparison of right- and left-hemisphere patients. Seizure 2000;9:189-97.
60. Trimble MR, Krishnamoorthy ES. Neuropsychiatric aspects of epilepsy: some transcultural issues. Epilepsia 2003;44(Suppl 1): 21-4.
61. Epilepsy: a report to the nation. Landover, MD: Epilepsy Foundation; 1999.
62. Baker GA, Brooks J, Buck D, Jacoby A. The stigma of epilepsy: a European perspective. Epilepsia 2000;41:98-104.
63. Radhakrishnan K, Pandian JD, Santoshkumar T, et al. Prevalence, knowledge, attitude and practice of epilepsy in Kerala, South India. Epilepsia 2000;41:1027-35.
64. Wright J, Pickard N, Whitfield A, Hakin N. A population based study of the prevalence, clinical characteristics and the effect of ethnicity on epilepsy. Seizure 2000;9:309-13.
65. Reynolds EH. The ILAE/IBE/WHO Global Campaign Against Epilepsy: bringing epilepsy out of the shadows. Epilepsy Behav 2000;1:S3-8.
66. Ustun TB, Von Korff M. Primary mental health services: access and provision of care. In: Ustun TB, Sartorius N, editors. Mental illness in general health care: an international study. Chichester: Wiley; 1995. p. 347-60.
67. Ustun TB, Sartorius N, editors. Mental illness in general health care: an international study. Chichester: Wiley; 1995.
68. Goldberg D, Lecrubier Y. Form and frequency of mental disorders across centres. In: Goldberg Ustun TB, Lecrubier Sartorius N, editors. Mental illness in general health care: an international study. Chichester: Wiley; 1995. p. 323-34.
69. Brugha TS, Jenkins R, Taub N, Meltzer H, Bebbington PE. A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med 2001;31:1001-13.
70. Devinsky O. The meaning of quality of life to patients with epilepsy. Epilepsy Behav 2000;1:S18-20.
71. Hsu SI. Somatisation among Asian refugees and immigrants as a culturally-shaped illness behaviour. Ann Acad Med Singapore 1999;28:841-5.